BlueSphere Bio Email Format

Biotechnology ResearchPennsylvania, United States11-50 Employees

BlueSphere Bio is a Pittsburgh-based biotechnology company focused on developing personalized T cell therapies for cancer. Its TCXpress platform aims to harness a patient's own T cells to recognize the cancer's unique molecular fingerprint, delivering rapid, individualized treatments while sparing normal tissues.

Its customers and stakeholders include oncology researchers and patients seeking precise, immune-based cancer therapies. A notable development in 2025 was the appointment of a new Chief Scientific Officer. The company has also pursued manufacturing partnerships with Celularity and a strategic collaboration with the National Cancer Institute to advance treatments for a rare respiratory disease.

Sign up for free to view info

Company overview Employee directory